VIA
SNY icon

Vident Investment Advisory’s Sanofi SNY Stock Holding History

Vident Investment Advisory’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-14,905
Closed -$803K – 900
2023
Q2 		$803K Sell
14,905
-2,894
-16% -$156K 0.03% 540
2023
Q1 		$969K Buy
17,799
+9,774
+122% +$475K 0.03% 535
2022
Q4 		$389K Buy
+8,025
New +$352K 0.01% 797

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Vident Investment Advisory's SNY Position: Q3 2023 in Review

Vident Investment Advisory sold out of Sanofi (SNY) in Q3 2023, closing a stake of 14,905 shares — an estimated $803K sold.

Vident Investment Advisory first reported a position in SNY in Q4 2022 and held it in 3 quarters. The position peaked at $969K in Q1 2023. 696 funds tracked by Wall St. Rank hold SNY as of Q3 2023.

  • Vident Investment Advisory reported no remaining Sanofi position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 14,905 Sanofi shares in Q3 2023, an estimated $803K.
  • Vident Investment Advisory first reported a position in Sanofi in Q4 2022 and held it in 3 quarters.
  • Vident Investment Advisory's Sanofi position peaked at $969K in Q1 2023.
  • 696 funds tracked by Wall St. Rank held Sanofi as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.